Cost-effectiveness comparison between ibrutinib, chemotherapy, and chemoimmunotherapy in front-line treatment of chronic lymphocytic leukemia (CLL) Meeting Abstract
| Authors: | Nabhan, C.; Nero, D.; Lee, C. H.; Kish, J. K.; Mato, A. R. |
| Abstract Title: | Cost-effectiveness comparison between ibrutinib, chemotherapy, and chemoimmunotherapy in front-line treatment of chronic lymphocytic leukemia (CLL) |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454842805037 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-118640 |
| Notes: | Meeting Abstract: 4757 -- Source: Wos |
